No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
www.scd.co.krNo one on the platform currently holds 000250.KQ.
No tracked institution reports a position in 000250.KQ as of their last filing.
No one on the platform has traded 000250.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.0% | — | — | — | ||
| Rev. Growth % | 9.9% | 6.8% | ||||
| Profit Margin % | 2.3% | -3.0% | 0.9% | |||
| Free Cash Flow Margin % | -15.7% | -13.0% | -4.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $141.8B | — | $398.00 | $398.00–$398.00 | — | 1 |
| 2028 | $186.4B | +31.5% | $739.00 | $739.00–$739.00 | — | 1 |
| 2029 | $188.9B | +1.3% | $312.00 | $312.00–$312.00 | — | 1 |
| 2030 | $170.4B | -9.8% | $450.00 | $450.00–$450.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000250.KQSam Chun Dang Pharm. Co., Ltd | $156100.00 | -0.89% | $3.65T | — |
| 006280.KSGC Biopharma Corp. | $122400.00 | -2.00% | $1.40T | — |
| 028300.KQHLB Co., Ltd. | $31900.00 | -1.69% | $4.24T | — |
| 128940.KSHanmi Pharm. Co., Ltd. | $502000.00 | +1.11% | $6.37T | — |
| 141080.KQLigaChem Biosciences Inc. | $82600.00 | -1.31% | $3.01T | — |
| 214150.KQCLASSYS Inc. | $32000.00 | +1.27% |
Source: Financial Modeling Prep · peers by sector/industry
| $2.09T |
| — |
| 214450.KQPharmaResearch Co., Ltd. | $331000.00 | -1.78% | $3.44T | — |